Meeting Coverage:

Aspen Retinal Detachment Society

ARDS: 2021

Track the History–and Future–of Anti-VEGF

Show Description +

Robert Avery, MD, shares what facinates him most about the history behind anti-VEGF–and what the future holds for the next generation of agents.

Posted: 2/23/2021

Up Next

ARDS Stays In-Person, Safely

Timothy G. Murray, MD, MBA


An Update on Surgical Approaches to Gene and Cell Therapies

Allen C. Ho, MD, Timothy G. Murray, MD, MBA

ROP in the Era of Anti-VEGF

R.V. Paul Chan, MD, MSc, MBA, FACS, Timothy G. Murray, MD, MBA

Advancements in Retinal Detachment Repair

Maria H. Berrocal, MD, Timothy G. Murray, MD, MBA

The Promise of Macular Reconstruction

Timothy W. Olsen, MD, Timothy G. Murray, MD, MBA

An Update on Brolucizumab One Year Later

Ryan Rich, MD; Timothy G. Murray, MD

Diabetic Retinopathy: Treat Them Early

Maria H. Berrocal, MD; Timothy G. Murray, MD

Track the History–and Future–of Anti-VEGF

Robert Avery, MD, shares what facinates him most about the history behind anti-VEGF–and what the future holds for the next generation of agents.

Posted: 2/23/2021


Please log in to leave a comment.

More From ARDS: 2021 Coverage

An Update on Brolucizumab One Year Later

Ryan Rich, MD; Timothy G. Murray, MD

Diabetic Retinopathy: Treat Them Early

Maria H. Berrocal, MD; Timothy G. Murray, MD

ARDS Stays In-Person, Safely

Timothy G. Murray, MD, MBA